TERAPIA CELULAR PARA EL TRATAMIENTO DE LA DIABETES: MAS ALLA DE LAS CELULAS MADRE

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Medicina-buenos Aires

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunomodulation by mesenchymal stem cells and clinical experience

  2011cited by this paper
• Islet Transplantation a Decade Later and Strategies for Filling a Half-Full Glass

  2010cited by this paper
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9

  2009cited by this paper
• Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes

  2009cited by this paper
• Insulin‐Secreting Cells from Human Eyelid‐Derived Stem Cells Alleviate Type I Diabetes in Immunocompetent Mice

  2009cited by this paper
• One Thousand Simultaneous Pancreas-Kidney Transplants at a Single Center With 22-Year Follow-Up

  2009cited by this paper
• Mesenchymal stem cells treated with rat pancreatic extract secrete cytokines that improve the glycometabolism of diabetic rats.

  2009cited by this paper
• Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

  2008cited by this paper
• Autologous Hematopoietic Stem Cell Transplantation for Type 1 Diabetes

  2008cited by this paper
• Transplantation of insulin-producing clusters derived from adult bone marrow stem cells to treat diabetes in rats.

  2008cited by this paper
• Immunomodulation by Mesenchymal Stem Cells

  2008cited by this paper
• Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

  2008cited by this paper
• Mechanisms of Immunomodulation by Mesenchymal Stem Cells

  2007cited by this paper
• The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF.

  2007cited by this paper
• Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis

  2007cited by this paper
• Mesenchymal stem cells: isolation, in vitro expansion and characterization.

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Mesenchymal stem cells: isolation, in vitro expansion and characterization.

  2006cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• Immune modulation by mesenchymal stem cells.

  2006cited by this paper
• Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue

  2006cited by this paper
• Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes.

  2005cited by this paper
• Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

  2005cited by this paper
• The efficacy of mesenchymal stem cells to regenerate and repair dental structures.

  2005cited by this paper
• Five-year follow-up after clinical islet transplantation.

  2005cited by this paper
• In vivo biological activity of exendin (1–30)

  2005cited by this paper
• Effects of liraglutide (NN2211), a long‐acting GLP‐1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes

  2005cited by this paper
• Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities

  2005cited by this paper
• Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy

  2005cited by this paper
• Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.

  2005cited by this paper
• Pancreas transplant outcomes for United States (US) and non‐US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004

  2005cited by this paper
• Mesenchymal stem cells: cell biology and potential use in therapy.

  2004cited by this paper
• Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes

  2004cited by this paper
• Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy

  2004cited by this paper
• [Mesenchymal stem cells. Differentiation and alternative source of neural tissue].

  2004cited by this paper
• Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.

  2004cited by this paper
• Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood

  2004cited by this paper
• Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

  2004cited by this paper
• Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not

  2003cited by this paper
• The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose.

  2003cited by this paper
• Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes.

  2003cited by this paper
• Clinical islet transplantation

  2003cited by this paper
• Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002.

  2002cited by this paper
• Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: Growth factor production

  2002cited by this paper
• In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells

  2002cited by this paper
• Human Marrow-Derived Mesenchymal Stem Cells (MSCs) Express Hematopoietic Cytokines and Support Long-Term Hematopoiesis When Differentiated Toward Stromal and Osteogenic Lineages

  2000cited by this paper
• Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.

  2000cited by this paper
• Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

  2000cited by this paper
• The pathogenesis of insulin-dependent diabetes mellitus.

  1994cited by this paper
• Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

  1993cited by this paper
• Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.

  1992cited by this paper
• Entero-insular axis and diabetes mellitus.

  1992cited by this paper
• [Long-term complications in diabetes mellitus].

  1989cited by this paper

• Adipose-derived mesenchymal stem cells and extracellular vesicles confer antitumor activity in preclinical treatment of breast cancer.

  2020cites this paper
• Adipose tissue stem cells in regenerative medicine

  2018cites this paper
• Application of Stem Cells in Ischemic Heart Disease

  2013cites this paper